Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/02/24
End: 07/31/29
Due: 07/31/30
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 06/30/27
Due: 06/30/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa | NCT06591793 | AAVantgarde Bio Srl | user2@example.com | None | 2024-07-02 | 2029-07-31 | 2030-07-31 | - | - | 2025-07-14 |
| An Observational Study in Children and Adults With Stargardt Disease | NCT06591806 | AAVantgarde Bio Srl | user2@example.com | None | 2024-05-01 | 2027-06-30 | 2028-06-30 | - | - | 2025-07-14 |